A Study of Ginsenoside H Dripping Pills for Advanced Non-Small Cell Lung Cancer (NSCLC)
Ginsenoside H dripping pills is a kind of traditional Chinese medicine(TCM), This study is being conducted to evaluate the efficacy and safety of ginsenoside H dripping pills in patients with advanced (stage ⅢB/Ⅳ) Non-small Cell Lung Cancer (Syndrome Of Qi-Deficiency) and explore the optimal dosage
Non-small Cell Lung Cancer (NSCLC)
DRUG: Ginsenoside H dripping pills|DRUG: Ginsenoside H dripping pills+Placebo|DRUG: Placebo
Progression-free survival (PFS), Evaluate progression free survival (PFS) in the 3 groups : 0 , every 8 weeks and the end of treatment, through study completion, an average of 1 year
Overall Survival (OS), Evaluate overall survival (OS) in the 3 groups, through study completion, an average of 1 year|Time to progression(TTP), Evaluate time to progression(TTP) in the 3 groups, through study completion, an average of 1 year|Quality of Life, \[0 , every 4 weeks and the end of treatment\] To determine the quality of life by using the European Organisation of Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) scales., through study completion, an average of 1 year|Symptoms scores of TCM, 0 , every 4 weeks and the end of treatment, through study completion, an average of 1 year|Cancer-related fatigue, Evaluate the fatigue degree in the 3 groups using the Chinese version of Brief Fatigue Index (BFI-C): 0 , every 4 weeks and the end of treatment, through study completion, an average of 1 year
Blood routine test, 0 , every 4 weeks during the period of 0 to 16 weeks, every 8 weeks after 16 weeks and the end of treatment, through study completion, an average of 1 year|Urine routine test, 0 , every 4 weeks during the period of 0 to 16 weeks, every 8 weeks after 16 weeks and the end of treatment, through study completion, an average of 1 year|Hepatic function, 0 , every 4 weeks during the period of 0 to 16 weeks, every 8 weeks after 16 weeks and the end of treatment, through study completion, an average of 1 year
Ginsenoside H dripping pills is a kind of traditional Chinese medicine(TCM), This study is being conducted to evaluate the efficacy and safety of ginsenoside H dripping pills in patients with advanced (stage ⅢB/Ⅳ) Non-small Cell Lung Cancer (Syndrome Of Qi-Deficiency) and explore the optimal dosage